Global VC OrbiMed Leads Series A Financing In Its Second China Start-up Investment
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Life sciences and health investment firm OrbiMed announced March 8 that it has led $6.6 million series A financing for Chinese dental company EA Inc., which is focusing on providing invisible orthodontic braces to China's rising middle class